Hemodynamic-based Assessment and Management of Cardiogenic Shock

Hemodynamic-based Assessment and Management of Cardiogenic Shock

Cardiogenic shock (CS) remains a deadly disease entity challenging patients, caregivers, and communities across the globe. CS can rapidly lead to the development of hypoperfusion and end-organ dysfunction, transforming a predictable hemodynamic event into a potential high-resource, intense, hemometa...

Full description

Bibliographic Details
Main Authors: Jaime Hernandez-Montfort, Diana Miranda, Varinder Kaur Randhawa, Jose Sleiman, Yelenis Seijo de Armas, Antonio Lewis, Ziad Taimeh, Paulino Alvarez, Paul Cremer, Bernardo Perez-Villa, Viviana Navas, Emad Hakemi, Mauricio Velez, Luis Hernandez-Mejia, Cedric Sheffield, Nicolas Brozzi, Robert Cubeddu, Jose Navia, Jerry D Estep
Format: Article
Language:English
Published: Radcliffe Medical Media 2022-02-01
Series:US Cardiology Review
Online Access:https://www.uscjournal.com/articleindex/usc.2021.12
Description
Summary:Cardiogenic shock (CS) remains a deadly disease entity challenging patients, caregivers, and communities across the globe. CS can rapidly lead to the development of hypoperfusion and end-organ dysfunction, transforming a predictable hemodynamic event into a potential high-resource, intense, hemometabolic clinical catastrophe. Based on the scalable heterogeneity from a cellular level to healthcare systems in the hemodynamic-based management of patients experiencing CS, we present considerations towards systematic hemodynamic-based transitions in which distinct clinical entities share the common path of early identification and rapid transitions through an adaptive longitudinal situational awareness model of care that influences specific management considerations. Future studies are needed to best understand optimal management of drugs and devices along with engagement of health systems of care for patients with CS.
ISSN:1758-3896
1758-390X

Similar Items